ArticleJournal of robotic surgery2026
Impact of patient factors on outcomes in robotic major and minor hepatectomy: importance of patient selection.
Article in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic approach to hepatectomy has shown promise in recent times. The aim of our study was to identify the impact of various patient variables on outcomes from robotic major and minor hepatectomy. Data on 167 consecutive robotic hepatectomy procedures at our institution was retrospectively analyzed. Perioperative outcomes were analyzed for both minor and major hepatectomy. For major hepatectomy (n = 66), factors associated with increased operative time included cirrhosis (301 vs. 257 min) and obesity (310 vs. 261 min). Estimated blood loss (EBL) was worse in patients with underlying cirrhosis (242 vs. 161 mL), obesity (215 vs. 148mL) and tumor size ≥ 10 cm (232 vs. 136mL). Length of hospital stay (LOS) was also longer with age ≥ 70 years (5.9 vs. 4.5 days), cirrhosis (5.6 vs. 4.6 days) and malignant tumor pathology (5.1 vs. 3.8 days). Similarly, increased postoperative complications were seen with cirrhosis and tumor size ≥ 10 cm. For minor hepatectomy (n = 101), operative time was longer in patients with cirrhosis (139 vs. 105 min), obesity (141 vs. 115 min) and posterior-superior (PS) liver resection (168 vs. 104 min). Similarly, EBL was higher in cirrhotic patients (163 vs. 58mL) and those with PS resection (152 vs. 64mL). Longer LOS was observed in elderly patients (2.9 vs. 2.0 days), cirrhosis (2.9 vs. 2.1 days) and PS resection (2.8 vs. 2.1 days). Our study offers a comprehensive understanding of the impact of clinicopathologic factors on outcomes and can be utilized as a guide to appropriate patient selection, especially for surgeons starting a robotic hepatectomy practice.
Indexed as
Identifiers
41533179What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.